Antonino Mulè

5PUBLICATIONS
58CO-AUTHORS
NanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Feb 24, 2026
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Raffaele Palmieri, Fabio Guolo, Luana Fianchi

|Dec 05, 2025
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Raffaele Palmieri, Fabio Guolo, Luana Fianchi

|Jul 05, 2024
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial.

Adriano Venditti, Alfonso Piciocchi, Anna Candoni

|May 10, 2024
Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia.

Roberto Bono, Giuseppe Sapienza, Stefania Tringali

Pageof 1

Frequent Collaborators

4 joint publications

Francesco Buccisano

4 joint publications

Adriano Venditti

4 joint publications

Raffaele Palmieri

4 joint publications

Maria Paola Martelli